Memory for Semantically Related Objects Differentiates Cognitively Unimpaired Autosomal Dominant Mutation Carriers
J T Fox-Fuller1, J E Martinez, A Baena
1Yakeel T. Quiroz, PhD, Associate Professor, Harvard Medical School, Departments of Psychiatry and Neurology, Massachusetts General Hospital Building #39 1st Ave., Suite #101, Charlestown, MA 02129, USA, Phone (617) 643-5944; Fax: (617) 726-5760;
Cognitively unimpaired individuals with autosomal dominant Alzheimer's disease (ADAD) mutations show early memory deficits. The Memory for Semantically Related Objects test (MESERO) detects these subtle Alzheimer's disease changes.
Area of Science:
- Neuroscience
- Genetics
- Cognitive Psychology
Background:
- Early Alzheimer's disease (AD) manifests as semantic access and working memory impairments.
- Autosomal dominant AD (ADAD) provides a model for studying preclinical AD.
- Identifying sensitive cognitive markers is crucial for early AD detection.
Purpose of the Study:
- To evaluate the Memory for Semantically Related Objects test (MESERO) for detecting early cognitive changes in ADAD mutation carriers.
- To compare the performance of cognitively unimpaired ADAD mutation carriers with non-carrier family members using the MESERO.
Main Methods:
- A cohort of 35 cognitively unimpaired ADAD mutation carriers and 26 non-carrier family members from Colombia participated.
- Participants completed the computerized MESERO, assessing memory for semantically related and unrelated object sets.
- Cognitive performance was analyzed by comparing scores between carriers and non-carriers.
Main Results:
- Cognitively unimpaired ADAD carriers exhibited significantly lower overall MESERO scores compared to non-carriers.
- The performance difference was primarily driven by poorer performance on semantically related object sets.
- No significant differences were observed in performance on semantically unrelated object sets between the groups.
Conclusions:
- The MESERO test demonstrates sensitivity to subtle, preclinical cognitive changes associated with ADAD.
- MESERO performance may serve as an early indicator of AD-related cognitive decline.
- Further research should validate MESERO in diverse populations, including those at risk for sporadic AD.
More Related Videos
12:28Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
08:22A Robust Polymerase Chain Reaction-based Assay for Quantifying Cytosine-guanine-guanine Trinucleotide Repeats in Fragile X Mental Retardation-1 Gene
Published on: September 16, 2019
Related Concept Videos
Pedigree Analysis
Genetic Variation
Genes exist in different versions called alleles,...
Multiple Allele Traits
Incomplete Dominance
Genetic Lingo
Mutations
